Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Earnings and Comprehensive Income

v3.20.2
Consolidated Statements of Earnings and Comprehensive Income - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2018
Net sales $ 738,691 $ 714,006 $ 642,993
Cost of sales 255,497 240,515 210,850
Gross margin 483,194 473,491 432,143
Operating expenses:      
Selling, general and administrative 260,583 264,359 240,636
Research and development 65,192 62,413 55,329
Total operating expenses 325,775 326,772 295,965
Operating income 157,419 146,719 136,178
Other income (expense):      
Interest expense (19,197) (21,705) (10,188)
Interest income 605 569 409
Other non-operating income (expense), net 137,650 (13,568) (447)
Total other income (expense), net 119,058 (34,704) (10,226)
Income before income taxes 276,477 112,015 125,952
Income taxes (benefit) 47,181 15,943 (198)
Net earnings 229,296 [1] 96,072 126,150
Other comprehensive income (loss):      
Foreign currency translation adjustments (9,963) (4,487) (1,572)
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax amounts disclosed in Note 8. (3,715) (9,537) 0
Unrealized gains (losses) on available-for-sale investments, net of tax of $398 in FY18 0 0 5,693
Other comprehensive income (loss) (13,678) (14,024) 4,121
Comprehensive income $ 215,618 $ 82,048 $ 130,271
Earnings per share:      
Basic (in dollars per share) $ 6.00 $ 2.54 $ 3.36
Diluted (in dollars per share) $ 5.82 $ 2.47 $ 3.31
Weighted average common shares outstanding:      
Basic (in shares) 38,201 37,781 37,476
Diluted (in shares) 39,401 38,892 38,055
[1] Amounts do not total due to rounding